The high-profile obesity drug developer priced the biotech sector’s biggest offering in years and will use the proceeds to ...
For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...
Add Yahoo as a preferred source to see more of our stories on Google. Lululemon launched its first product using plant-based nylon in April 2023 Biotechnology is the exploitation of biological ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...
-- PanGIA Analysis System, a novel machine learning platform for non-invasive diagnosis of oral cancer through an oral sample -- PanGIA Analysis System, a novel machine learning platform for ...
This oncology-focused biotech, advancing multiple clinical-stage therapeutics, just reported a notable insider sale in recent ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results